Antimullerian hormone levels after laparoscopic endometrioma stripping surgery

被引:64
作者
Ercan, Cihangir Mutlu [1 ]
Sakinci, Mehmet [1 ]
Duru, Namik Kemal [1 ]
Alanbay, Ibrahim [1 ]
Karasahin, Kazim Emre [1 ]
Baser, Iskender [1 ]
机构
[1] Gulhane Mil Med Fac, Dept Obstet & Gynecol, TR-06018 Ankara, Turkey
关键词
ANTI-MULLERIAN HORMONE; OVARIAN RESERVE; PREGNANCY; MARKER;
D O I
10.3109/09513591003632134
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Method. Fourty-seven women participated as the study group in this prospective controlled trial, 33 of whom (70.2%) had unilateral and 14 (29.7%) of whom had bilateral endometriomas. Pre- and post-operative serum AMH levels were measured and compared with 17 normo-ovulatory control cases and also correlated with endometrioma sizes. Result(s). Mean pre-operative AMH levels of the study group and the normo-ovulatory control cases did not reveal a statistically significant difference (1.62 +/- 1.09 ng/ml and 2.06 +/- 0.51 ng/ml, P > 0.05). Mean level of post-operative serum AMH of the study group decreased from 1.62 +/- 1.09 to 1.39 +/- 1.16. However, this reduction was not statistically significant. (P > 0.05). Pre- and post-operative AMH levels do not reveal a correlation with the size of endometrioma in both group of patients with either unilateral or bilateral endometrioma. Conclusion(s). The presence of the endometrioma does not impair the AMH levels. Laparoscopic endometrioma stripping surgery do not appear to cause a damage in the AMH secreting healthy ovarian tissue, in the short-term follow-up. Laparoscopic stripping surgery of endometriomas in experienced hands is currently a valid approach.
引用
收藏
页码:468 / 472
页数:5
相关论文
共 17 条
[1]   Ovarian reserve testing and the use of prognostic models in patients with subfertility [J].
Bukman, A ;
Heineman, MJ .
HUMAN REPRODUCTION UPDATE, 2001, 7 (06) :581-590
[2]  
CHANG HJ, 2009, FERTIL IN PRESS 0402, DOI DOI 10.1016/J.FERTNSTERT.2009.02.022
[3]   Antimullerian hormone serum levels: a putative marker for ovarian aging [J].
de Vet, A ;
Laven, JSE ;
de Jong, FH ;
Themmen, APN ;
Fauser, BCJM .
FERTILITY AND STERILITY, 2002, 77 (02) :357-362
[4]   Large ovarian endometriomas [J].
Donnez, J ;
Nisolle, M ;
Gillet, N ;
Smets, M ;
Bassil, S ;
CasanasRoux, F .
HUMAN REPRODUCTION, 1996, 11 (03) :641-646
[5]   Serum anti-Mullerian hormone dynamics during controlled ovarian hyperstimulation [J].
Fanchin, R ;
Schonäuer, LM ;
Righini, C ;
Frydman, N ;
Frydman, R ;
Taieb, J .
HUMAN REPRODUCTION, 2003, 18 (02) :328-332
[6]   Management of endometriomas in women requiring IVF: to touch or not to touch [J].
Garcia-Velasco, Juan A. ;
Somigliana, Edgardo .
HUMAN REPRODUCTION, 2009, 24 (03) :496-501
[7]   Anti-Mullerian hormone and its role in ovarian function [J].
Gruijters, MJG ;
Visser, JA ;
Durlinger, ALL ;
Themmen, APN .
MOLECULAR AND CELLULAR ENDOCRINOLOGY, 2003, 211 (1-2) :85-90
[8]   Results of laparoscopic treatments of ovarian endometriomas: laparoscopic ovarian fenestration and coagulation [J].
Hemmings, R ;
Bissonnette, F ;
Bouzayen, R .
FERTILITY AND STERILITY, 1998, 70 (03) :527-529
[9]   PREVALENCE AND GENESIS OF ENDOMETRIOSIS [J].
MAHMOOD, TA ;
TEMPLETON, A .
HUMAN REPRODUCTION, 1991, 6 (04) :544-549
[10]   Evaluation of the utility of multiple endocrine and ultrasound measures of ovarian reserve in the prediction of cycle cancellation in a high-risk IVF population [J].
McIlveen, M. ;
Skull, J. D. ;
Ledger, W. L. .
HUMAN REPRODUCTION, 2007, 22 (03) :778-785